Delivery Order SPE2DB22D1202-SPE2DB25FVKJ5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,581.99 to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampuls on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,251.88 to AmerisourceBergen Drug Corp for the supply of Duramorph 10 mg/10 mL ampules. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's pharmaceutical supply services to support federal...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,617.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DURAMORPH 10MG/10ML 10 medical products. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
- The Defense Logistics Agency awarded a $1,150.31 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Duramorph 10 mg/10 mL ampuls. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025. Performance will take place at AmerisourceBergen's Corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The award, valued at $1,130.00, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $2,042.55 for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 7, 2024 and is a Firm Fixed Price type. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract is associated with a larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,649,492 units of the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML. The delivery order has a completion date of February 14, 2024 and a potential value of $3,385.23. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not have a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 10 MG/10 ML AMPUL 10ML pharmaceutical products. The contract has a completion date of February 9, 2024 and a potential value of $1,495.11. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supplies to U.S. government agencies, including the Department...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a medical product, with a ceiling value of $1,698.81 and a performance period ending on May 19, 2025. The contract is a firm fixed-price delivery order, indicating competitive procurement without a set-aside designation. Amerisourcebergen...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,781.70 order is for DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKJ5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,643.30 to AmerisourceBergen Drug Corp for the supply of Duramorph 10 mg/10 mL ampuls on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal medical procurement contracts with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. All of AmerisourceBergen's reviewed contract awards with DLA have been competitively awarded without set-aside designations, demonstrating the contractor's capability to meet rigorous federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/4/25 |